Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer.
Dhillon PK, Penney KL, Schumacher F, Rider JR, Sesso HD, Pollak M, Fiorentino M, Finn S, Loda M, Rifai N, Mucci LA, Giovannucci E, Stampfer MJ, Ma J. Dhillon PK, et al. Among authors: rider jr. Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2618-27. doi: 10.1158/1055-9965.EPI-11-0434. Epub 2011 Sep 29. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21960694 Free PMC article. Clinical Trial.
The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis.
Pettersson A, Graff RE, Bauer SR, Pitt MJ, Lis RT, Stack EC, Martin NE, Kunz L, Penney KL, Ligon AH, Suppan C, Flavin R, Sesso HD, Rider JR, Sweeney C, Stampfer MJ, Fiorentino M, Kantoff PW, Sanda MG, Giovannucci EL, Ding EL, Loda M, Mucci LA. Pettersson A, et al. Among authors: rider jr. Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1497-509. doi: 10.1158/1055-9965.EPI-12-0042. Epub 2012 Jun 26. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22736790 Free PMC article.
A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer.
Schoenfeld JD, Margalit DN, Kasperzyk JL, Shui IM, Rider JR, Epstein MM, Meisner A, Kenfield SA, Martin NE, Nguyen PL, Kantoff PW, Giovannucci EL, Stampfer MJ, Mucci LA. Schoenfeld JD, et al. Among authors: rider jr. Clin Cancer Res. 2013 Mar 15;19(6):1612-9. doi: 10.1158/1078-0432.CCR-12-2718. Epub 2013 Feb 4. Clin Cancer Res. 2013. PMID: 23382116 Free PMC article.
Gleason grade progression is uncommon.
Penney KL, Stampfer MJ, Jahn JL, Sinnott JA, Flavin R, Rider JR, Finn S, Giovannucci E, Sesso HD, Loda M, Mucci LA, Fiorentino M. Penney KL, et al. Among authors: rider jr. Cancer Res. 2013 Aug 15;73(16):5163-8. doi: 10.1158/0008-5472.CAN-13-0427. Cancer Res. 2013. PMID: 23946472 Free PMC article.
SPINK1 protein expression and prostate cancer progression.
Flavin R, Pettersson A, Hendrickson WK, Fiorentino M, Finn S, Kunz L, Judson GL, Lis R, Bailey D, Fiore C, Nuttall E, Martin NE, Stack E, Penney KL, Rider JR, Sinnott J, Sweeney C, Sesso HD, Fall K, Giovannucci E, Kantoff P, Stampfer M, Loda M, Mucci LA. Flavin R, et al. Among authors: rider jr. Clin Cancer Res. 2014 Sep 15;20(18):4904-11. doi: 10.1158/1078-0432.CCR-13-1341. Epub 2014 Mar 31. Clin Cancer Res. 2014. PMID: 24687926 Free PMC article.
Genetic variation across C-reactive protein and risk of prostate cancer.
Markt SC, Rider JR, Penney KL, Schumacher FR, Epstein MM, Fall K, Sesso HD, Stampfer MJ, Mucci LA. Markt SC, et al. Among authors: rider jr. Prostate. 2014 Jul;74(10):1034-42. doi: 10.1002/pros.22820. Epub 2014 May 20. Prostate. 2014. PMID: 24844401 Free PMC article.
Circadian clock genes and risk of fatal prostate cancer.
Markt SC, Valdimarsdottir UA, Shui IM, Sigurdardottir LG, Rider JR, Tamimi RM, Batista JL, Haneuse S, Flynn-Evans E, Lockley SW, Czeisler CA, Stampfer MJ, Launer L, Harris T, Smith AV, Gudnason V, Lindstrom S, Kraft P, Mucci LA. Markt SC, et al. Among authors: rider jr. Cancer Causes Control. 2015 Jan;26(1):25-33. doi: 10.1007/s10552-014-0478-z. Epub 2014 Nov 12. Cancer Causes Control. 2015. PMID: 25388799 Free PMC article.
Tumor expression of adiponectin receptor 2 and lethal prostate cancer.
Rider JR, Fiorentino M, Kelly R, Gerke T, Jordahl K, Sinnott JA, Giovannucci EL, Loda M, Mucci LA, Finn S; Transdisciplinary Prostate Cancer Partnership (ToPCaP). Rider JR, et al. Carcinogenesis. 2015 Jun;36(6):639-47. doi: 10.1093/carcin/bgv048. Epub 2015 Apr 11. Carcinogenesis. 2015. PMID: 25863129 Free PMC article.
Sleep Duration and Disruption and Prostate Cancer Risk: a 23-Year Prospective Study.
Markt SC, Flynn-Evans EE, Valdimarsdottir UA, Sigurdardottir LG, Tamimi RM, Batista JL, Haneuse S, Lockley SW, Stampfer M, Wilson KM, Czeisler CA, Rider JR, Mucci LA. Markt SC, et al. Among authors: rider jr. Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):302-8. doi: 10.1158/1055-9965.EPI-14-1274. Epub 2015 Dec 16. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26677208 Free PMC article.
Cholesterol Metabolism and Prostate Cancer Lethality.
Stopsack KH, Gerke TA, Sinnott JA, Penney KL, Tyekucheva S, Sesso HD, Andersson SO, Andrén O, Cerhan JR, Giovannucci EL, Mucci LA, Rider JR. Stopsack KH, et al. Among authors: rider jr. Cancer Res. 2016 Aug 15;76(16):4785-90. doi: 10.1158/0008-5472.CAN-16-0903. Epub 2016 Jun 20. Cancer Res. 2016. PMID: 27325648 Free PMC article.
120 results